DJIA 17,646.00 -43.86 -0.25%
NASDAQ 5,134.05 5.77 0.11%
S&P 500 2,101.58 -2.26 -0.11%
market minute promo

Celgene (NASDAQ: CELG)

company name or ticker

Piper Jaffray Still Overweight Biogen But Notes It's Least-Preferred Play; Hikes Celgene Target

Celgene (CELG) Hits New Lifetime High

3 Questions Investors Should Ask When Celgene Reports Its Second-Quarter Results

Celgene's Q2 report is right around the corner. Here are three questions investors should keep in mind.

Jim Cramer's Top Takeaways: Celgene, Facebook,, Netflix, Google

The Melting Pot Portfolio: First Inning

The Most Important Question For Celgene Investors After The Receptos Acquisition

Top Health Care Earnings for the Week Ahead

NFLX, CELG, M, GS: Jim Cramer's Views

Is Celgene Brilliant or Downright Crazy?

Celgene is spending big money on deals that could significantly impact its future.

So You Missed Out On Receptos... Who's Next?

See More Articles...